Acorda Therapeutics
ACOR
#10358
Rank
C$1.13 M
Marketcap
$0.91
Share price
0.00%
Change (1 day)
-95.64%
Change (1 year)

Earnings for Acorda Therapeutics (ACOR)

Earnings in 2024 (TTM): -C$0.37 Billion

According to Acorda Therapeutics 's latest financial reports the company's current earnings are C$0.11 Billion. In 2023 the company made an earning of -C$0.37 Billion a decrease over its 2022 earnings that were of -C$7.37 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Acorda Therapeutics from 2006 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -C$0.37 Billion-0.96%
2023 -C$0.37 Billion4848.63%
2022 -C$7.37 Million-93.25%
2021 -C$0.11 Billion2.52%
2020 -C$0.11 Billion-69.45%
2019 -C$0.35 Billion-700.62%
2018 C$57.98 M-118.02%
2017 -C$0.33 Billion805.99%
2016 -C$35.53 Million-173.88%
2015 C$48.08 M-6.58%
2014 C$51.47 M20.19%
2013 C$42.82 M18.7%
2012 C$36.07 M-26.54%
2011 C$49.11 M
2009 -C$0.12 Billion10.65%
2008 -C$0.11 Billion86.17%
2007 -C$54.45 Million68.1%
2006 -C$32.39 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-C$8.71 Million-97.68%๐Ÿ‡บ๐Ÿ‡ธ USA
C$0.74 B-299.34%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$0.11 Billion-71.85%๐Ÿ‡ฉ๐Ÿ‡ช Germany
C$0.35 B-195.95%๐Ÿ‡บ๐Ÿ‡ธ USA